Two phenotypes that predict prognosis in lung adenocarcinoma
- PMID: 35798373
- DOI: 10.1183/13993003.00569-2022
Two phenotypes that predict prognosis in lung adenocarcinoma
Conflict of interest statement
Conflict of interest: L. Kalinke has nothing to disclose. S.M. Janes reports paid advisory roles for AstraZeneca, Bard1 Bioscience, Achilles Therapeutics and Jansen; received assistance for travel to meetings from AstraZeneca and Takeda; and is the investigator lead on grants from GRAIL Inc, GlaxoSmithKline plc and Owlstone.
Comment on
-
Prognostic phenotypes of early-stage lung adenocarcinoma.Eur Respir J. 2022 Jul 7;60(1):2101674. doi: 10.1183/13993003.01674-2021. Print 2022 Jul. Eur Respir J. 2022. PMID: 34887322
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical